The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Sagimet Biosciences Inc (NASDAQ: SGMT) closed the day trading at $6.81 up 4.45% from the previous closing price of $6.52. In other words, the price has increased by $4.45 from its previous closing price. On the day, 0.63 million shares were traded. SGMT stock price reached its highest trading level at $6.975 during the session, while it also had its lowest trading level at $6.36.
Ratios:
For a better understanding of SGMT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.47 and its Current Ratio is at 17.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Wedbush on August 11, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 21 ’25 when Happel David sold 65,478 shares for $9.13 per share. The transaction valued at 598,115 led to the insider holds 689,722 shares of the business.
Martins Eduardo Bruno sold 8,277 shares of SGMT for $75,607 on Jul 21 ’25. The Chief Medical Officer now owns 106,936 shares after completing the transaction at $9.13 per share. On Jul 21 ’25, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,780 shares for $9.13 each. As a result, the insider received 98,471 and left with 183,726 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 221472096 and an Enterprise Value of 96217088.
Stock Price History:
The Beta on a monthly basis for SGMT is 3.27, which has changed by 1.3811188 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is -16.06%, while the 200-Day Moving Average is calculated to be 24.95%.
Shares Statistics:
Over the past 3-months, SGMT traded about 778.78K shares per day on average, while over the past 10 days, SGMT traded about 547400 shares per day. A total of 30.67M shares are outstanding, with a floating share count of 26.13M. Insiders hold about 19.66% of the company’s shares, while institutions hold 29.63% stake in the company. Shares short for SGMT as of 1756425600 were 2412557 with a Short Ratio of 3.10, compared to 1753920000 on 3211457. Therefore, it implies a Short% of Shares Outstanding of 2412557 and a Short% of Float of 8.4.
Earnings Estimates
Its stock is currently analyzed by 8.0 different market analysts. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.34 and low estimates of -$0.77.
Analysts are recommending an EPS of between -$1.56 and -$2.24 for the fiscal current year, implying an average EPS of -$1.7. EPS for the following year is -$2.05, with 9.0 analysts recommending between -$1.54 and -$2.78.
